RecallDepth
Class II Ongoing

Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
November 7, 2024
Posted
December 11, 2024
Recall Number
D-0078-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3336 bottles
Firm Location
East Windsor, NJ, United States

Reason for Recall

cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Distribution

USA Nationwide

Lot / Code Info

Lot #: a) CFSB23001A, Exp 03/31/2025, CFSB23002A, Exp 07/31/2025; CFSB23003A, Exp 10/31/2025; CFSB23004A, Exp 10/31/2025; b) P2300196, 12/31/2024

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls